Chorionic Gonadotropin

N/A

Report date: 2022/12/15 20:00:39

Base Information

Drug NameChorionic Gonadotropin
Drug Alias Name绒毛膜促性腺激素LDI-200
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis stimulantsDeoxyribonuclease 1 stimulantsRNA inhibitors
TargetsRibonucleic AcidDeoxyribonuclease 1
Therapy Area/IndicationsHypogonadismInfertility, FemaleCryptorchidism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAngiogene Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesFerring Pharmaceuticals Ltd
Inactive CompaniesAngiogene PharmaceuticalsAska Pharmaceutical Co LtdPfizer Inc +[4] 
Active IndicationsHypogonadismInfertility, FemaleCryptorchidism
Inactive IndicationsProstatic NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A